An optimized peptide vaccine strategy capable of inducing multivalent CD8+ T cell responses with potent antitumor effects

Therapeutic cancer vaccines are an attractive alternative to conventional therapies for treating malignant tumors, and successful tumor eradication depends primarily on obtaining high numbers of long-lasting tumor-reactive CD8+ T cells. Dendritic cell (DC)-based vaccines constitute a promising appro...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Hyun-Il Cho, Soo-Hyun Jung, Hyun-Jung Sohn, Esteban Celis, Tai-Gyu Kim
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Taylor & Francis Group 2015-11-01
Colecção:	OncoImmunology
Assuntos:	cancer vaccine dendritic cells heterologous prime-boost vaccination multivalent CD8+ T cells peptide-based vaccine tumor immunity
Acesso em linha:	https://www.tandfonline.com/doi/10.1080/2162402X.2015.1043504
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!